跳至主要内容
临床试验/NCT03390257
NCT03390257已完成不适用

Safety and Effectiveness Evaluation of the Sinusway™ Device for Endoscopy of the Nasal Cavity and Paranasal Sinuses in Conjunction With Sinus Balloon Dilation

3NT Medical Ltd.4 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2017年4月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
14
试验地点
4
主要终点
Number of Adverse Device Effects

研究概览

简要总结

3NT flexible endoscope is a single-use disposable handheld endoscope that provides a means to visualize the nasal cavity and paranasal sinus space and deliver irrigation to treat the sinus ostia and spaces within the paranasal sinus cavities for diagnostic and therapeutic procedures

详细描述

The rationale behind this feasibility study is to show that access and visualization of the nasal anatomy and paranasal sinuses (Maxillary, Frontal and Sphenoid sinuses) in conjunction with Balloon Sinus Dilation in patients suffering from symptoms attributable to sinusitis is feasible in the office and operating room settings; This is an essential step in the development of a combined dilation and visualization system that will allow visualization, dilation and lavage of the sinuses via their natural ostia during an office visit, and minimize radiation exposure, antibiotic use, multiple office visits, and cost.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female patient indicated for balloon sinus dilation procedure by the ENT specialist
  • Patient age: adult (>18 years old)
  • Patients in general good health in the opinion of the investigator as determined by medical history and physical examination
  • A patient who is able to understand the requirements of the study, is willing to comply with its instructions and schedules, and agrees to sign the informed consent

排除标准

  • Known history of any significant medical disorder, which in the investigator's judgment contraindicates the patient's participation
  • Patients with known current or previous bleeding disorder receiving anticoagulants (e.g., chronic Coumadin treatment)

结局指标

主要结局

Number of Adverse Device Effects

时间窗: 4 hours

Number of Adverse Device Effects is expected to be similar to the number reported in literature for Nasal Endoscopy

次要结局

  • User Satisfaction (1-bad, 5-good)(1 hour)
  • Percent of Sinuses Accessed and Visualized Successfully(1 hour)

研究者

发起方
3NT Medical Ltd.
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验